Earlier quoted context omitted.
Every disease is a different beast, and biology is very hard to tame. We've thrown probably trillions of dollars at cancer over the past few decades, and only in the past few years, with immuno-oncology, has there been any real hope of progress toward broad cures (there was a heady moment after Gleevec, too, but that turned out to be the exception rather than the rule). There was just a huge wave of Alzheimer's treat…
To be fair though, we are really close with cancer. Like really really close. cfDNA is revolutionary for our measurements. Crispr is revolutionary for understanding. So close.
Just curious, on what do you base this opinion? Do you work in cancer research, or another biomedical field? These tools will definitely advance our understanding, but my feeling (as someone who worked in genomics for several years, though not in cancer) is that if you think "we are really close" to curing cancer (pardon me if I misinterpreted your statement) with these technologies, you are buying into a lot of hype around them. It's natural that that hype exists, though, given how much VC money is being poured into this area right now.